Spectrum Pharmaceuticals develops and commercializes cancer therapies, including Rolvedon (formerly eflapegrastim), a long-acting G-CSF for treating chemotherapy-induced neutropenia (CIN). The FDA's ...

Spectrum Brands Holdings faces structural concerns despite operational strengths, with sluggish revenue growth and declining sales in key divisions raising red flags for investors. Tariff impacts and ...

ALPHA published a paper in the journal Nature this week that reports the first ever measurement of the optical spectrum of an antimatter atom. The team behind the paper says that this is the result of ...

The traditional view of antiproteases is that their important and principal function is to complex with and inhibit various types of proteases and thus prevent or down-regulate proteolytic tissue ...

“You always have to make certain market assumptions,” Harbinger Capital Investments founder Phil Falcone said at Delivering Alpha in September 2011. “My assumptions are that mosquitoes will still bite ...

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.